论文部分内容阅读
患者男,27岁,因皮肤瘙痒半月余,2013年4月27日来我院皮肤科就诊。体检:四肢及躯干出现片状红斑、风团,界限不清。既往无药物及食物过敏史。诊断为荨麻疹。给予盐酸非索非那定片(江苏恒瑞医药股份有限公司,批号:1209285)60 mg,po,bid;清开灵分散片(哈药集团三精千鹤制药有限公司,批号:20130102)0.9 g,po,tid。患者于当日12:30服用清开灵分散片,身体未出现不适,睡前服用盐酸非索非那定片60 mg、清开灵分散片0.9 g,5 min后患者出现
Male patient, 27 years old, due to skin itching more than half a month, April 27, 2013 to our hospital dermatology clinic. Physical examination: flaky erythema appeared on limbs and torso, wind group, unclear boundaries. Past history of drug and food allergy. Diagnosis of urticaria. Given fexofenafine hydrochloride tablets (Jiangsu Hengrui Pharmaceutical Co., Ltd., batch number: 1209285) 60 mg, po, bid; Qingkailing dispersible tablets (Harbin Pharmaceutical Group Sanchong Qianhe Pharmaceutical Co., Ltd., batch number: 20130102) 0.9 g, po, tid. Patients at 12:30 on the day of taking Qing Kai Ling dispersible tablets, the body does not appear discomfort, before taking bed fexofenadine tablets 60 mg, Qing Kai Ling dispersible tablets 0.9 g, 5 min after the patient